Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Ann Rheum Dis. 2021 Nov; 80(11):1436-1444.

Objectives:

To compare the benefits of a tight-control/treat-to-target strategy (TC/T2T) in axial spondyloarthritis (axSpA) with those of usual care (UC).

 

https://pubmed.ncbi.nlm.nih.gov/33958325/

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs  in Rheumatoid Arthritis: Results from the 2‑Year  Longitudinal Prospective Non‑interventional  STRATEGE2 Study
Actualités RCTS - Publications - Rhumatologie - Facultatif

Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs in Rheumatoid Arthritis: Results from the 2‑Year Longitudinal Prospective Non‑interventional STRATEGE2 Study

methotrexate maintenance RA
Actualités RCTS - Publications - Rhumatologie - Facultatif

Methotrexate Maintenance RA: STRATEGE2 2‑Year Study

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates
Publications - Success stories - Rhumatologie - Facultatif

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates